Drug Discovery & Development | Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies Xconomy Seattle Genetics is best known for its one successful marketed cancer drug, but it has been busy working behind the scenes for years on new technologies for making souped-up antibodies against cancer. Now AbbVie has agreed to pay $25 million to gain ... Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with ... Seattle Genetics, AbbVie Broaden Partnership |
